Low TNF-induced NF-κB and p38 phosphorylation levels in leucocytes in tumour necrosis factor receptor-associated periodic syndrome

Rheumatology

Volumn 49, Issue 2, 2010, Pages 382-390

  Stjernberg Salmela, Susanna ^a   Ranki, Annamari ^a   Karenko, Leena ^a   Siitonen, Sanna ^a   Mustonen, Harri ^b   Puolakkainen, Pauli ^b   Sarna, Seppo ^a   Pettersson, Tom ^b   Repo, Heikki ^c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Autoinflammatory disorder; Nuclear factor B signalling; TNF; TNFRSF1A

Indexed keywords

ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; C REACTIVE PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STAT1 PROTEIN; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE MUTATION; HUMAN; INNATE IMMUNITY; LEUKOCYTE; LYMPHOCYTE; MONOCYTE; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME;

C-REACTIVE PROTEIN; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FAMILIAL MEDITERRANEAN FEVER; HUMANS; LEUKOCYTES; MUTATION; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950419556     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep327     Document Type: Article

References (38)

1. McDermott MF, Aksentijevich I, Galon J et al. Germline mutations in the extracellular domains of the 55 kD TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999;97:282-5.
2. Stojanov S, Kastner DL. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005;17:586-99.
3. McEwan DJ. TNF receptor subtype signalling: differences and cellular consequences. Cell Signal 2002;14:477-92.
4. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001;11:372-7.
5. Courtois G. The NF-κB signaling pathway in human genetic diseases. Cell Mol Life Sci 2005;62:1682-91.
6. Chen LW, Chen PH, Chang WJ, Wang JS, Karin M, Hsu CM. IkB-kinase/nuclear factor-κB signaling prevents thermal injury-induced gut damage by inhibiting c-Jun NH2-terminal kinase activation. Crit Care Med 2007;35: 1332-40.
7. mapk, MKK3, and MKK4 by TNF-α in mouse bone marrow-derived macrophages. J Immunol 1997;159:4491-7.
8. O'Shea JJ, Gadina M, Schreiber RD. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 2002;109(Suppl.):S121-31.
9. Sarrauste de Menthiere C, Terriere S, Pugnere D, Ruiz M, Demaille J, Touitou I. INFEVERS: the registry for FMF and hereditary inflammatory disorders mutations. Nucleic Acids Res 2003;31:282-5.
10. Siebert S, Amos N, Fielding CA et al. Reduced tumor necrosis factor signaling in primary human fibroblasts containing a tumor necrosis factor receptor superfamily 1A mutant. Arthritis Rheum 2005;25:1287-92.
11. Lobito AA, Kimberley FC, Muppidi JR et al. Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS). Blood 2006;108:1320-7.
12. Nevala H, Karenko L, Stjernberg S et al. A novel mutation in the third extracellular domain of the tumor necrosis factor receptor 1 in a Finnish family with autosomal-dominant recurrent fever. Arthritis Rheum 2002;46: 1061-6.
13. Stjernberg-Salmela S, Pettersson T, Karenko L et al. A novel tumour necrosis factor receptor mutation in a Finnish family with periodic fever syndrome. Scand J Rheumatol 2004;33:140-4.
14. Banner DW, D'Arcy A, Janes W et al. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 1993;73:431-45.
15. Välimäki M, Anttila PM, Pentikäinen PJ, Törnroth T, Maury P, Nyman JA. Mediterranean fever in Finland? (in Finnish). Duodecim 1985;101:2428-32.
16. Karenko L, Pettersson T, Roberts P. Autosomal dominant 'Mediterranean fever' in a Finnish family. J Intern Med 1992;232:365-9; Erratum in J Intern Med 1993;233:101.
17. Fleischer T, Dorman S, Anderson JA, Vail M, Brown MR, Holland SM. Detection of intracellular phosphorylated STAT-1 by flow cytometry. Clinical Immunol 1999;90:425-30.
18. Vakkila J, Nieminen U, Siitonen S et al. A novel modification of a flow cytometric assay of phosphorylated STAT1 in whole blood monocytes for immunomonitoring of patients on IFNα regimen. Scand J Immunol 2008;67: 95-102.
19. BD Phosflow Protocol III for Human Whole Blood. www.bdbiosciences.com/support/resources/protocols/protocol_hwbs.jsp#search=Phosflow [4 November 2009, date last accessed].
20. Sucic M, Kolevska T, Kopjar B et al. Accuracy of routine flow-cytometric bitmap selection for three leukocyte populations. Cytometry 1989;10:442-7.
21. Lesinski GB, Kondadasula SV, Crespin T et al. Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy. J Natl Cancer Inst 2004;96:1331-42.
22. Siebert S, Fielding CA, Williams BD, Brennan P. Mutation of the extracellular domain of tumour necrosis factor receptor 1 causes reduced NF-κB activation due to decreased surface expression. FEBS Lett 2005;579:5193-8.
23. Yousaf N, Gould DJ, Aganna E et al. Tumor necrosis factor receptor I from patients with tumor necrosis factor receptor-associated periodic syndrome interacts with wild-type tumor necrosis factor receptor I and induces ligand-independent NF-kappaB activation. Arthritis Rheum 2005;52:2906-16.
24. Kimberely F, Lobito AA, Siegel RM, Screaton GR. Falling into TRAPS - receptor misfolding in the TNF receptor 1-associated periodic fever syndrome. Arthritis Res Ther 2007;9:217.
25. Nedjai B, Hitman GA, Yousaf N et al. Abnormal TNFR1 cell surface expression and NF-κB activation in TNFR1-associated periodic fever syndrome (TRAPS). Arthritis Rheum 2008;58:273-83.
26. Härtel C, Bein G, Muller-Steinhardt M, Kluter H. Ex vivo induction of cytokine mRNA expression in human blood samples. J Immunol Methods 2001;249:63-71.
27. Calafat J, Kuijpers TW, Hanssen H, Borregaard N, Verhoeven AJ, Roos D. Evidence for small intracellular vesicles in human blood phagocytes containing cytochrome b558 and the adhesion molecule CD11b/CD18. Blood 1993;81:3122-9.
28. Berger M, O'Shea, J, Cross AS et al. Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. J Clin Invest 1984;74:1566-71.
29. Kizkai T, Suzuki K, Hitomi Y et al. Activation and apoptosis of murine peritoneal macrophages by acute cold stress. Biochem Biophys Res Commun 2001;283:700-6.
30. Haslett C, Guthrie LA, Kopaniak MM, Johnston RB Jr, Henson PM. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 1985;119:101-10.
31. Repo H, Jansson SE, Leirisalo-Repo M. Flow cytometric determination of CD11b upregulation in vivo. J Immunol Methods 1993;164:193-202.
32. Repo H, Jansson SE, Leirisalo-Repo M. Anticoagulant selection influences flow cytometric determination of CD11b upregulation in vivo and ex vivo. J Immunol Methods 1995;185:65-79.
33. Simon A, van der Meer JW. Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes. Am J Physiol Regul Integr Comp Physiol 2007;292:R86-98.
34. Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
35. van Heel DA, Ghosh S, Butler M et al. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet 2005;365:1794-6.
36. Korzenik JR. Is Crohn's disease due to defective immunity? Gut 2007;56:2-5.
37. Greten FR, Arkan MC, Bollrath J et al. NF-κB is a negative regulator of IL-1β secretion as revealed by genetic and pharmcological inhibition of IKKβ. Cell 2007;130:918-31.
38. Matsuzawa A, Tseng PH, Vallabhapurapu S et al. Essential cytoplasmic translocation of a cytokine receptorassembled signaling complex. Science 2008;321:663-8.